Advertisement
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
This site complies with the HONcode standard for trustworthy health information: verify here .
Susan Hasty, Publisher
Table of Contents . . . February 27th, 2006
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Pharma Business Week | Other Publications
Drug Development - Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis
Market Analysis - Generics erosion will lead to slow market growth for chronic heart failure treatment
Market Analysis - Report finds every 1% increase in generic dispensing cuts pharmaceutical expenditures by 0.6%
Marketing - Market report says 2006 launch of cancer vaccine to prevent human papillomavirus expected
Pharmaceutical Research - Market research firm study shows companies spent more than $1 trillion on acquisitions in 2005
Addiction Medicine - Study supports a flexible approach to methadone dosing
Adverse Drug Reactions - Anticholinergic drugs linked to mental impairment in elderly people
Age-Related Macular Degeneration - European commission approves Macugen for treatment of all types of wet AMD
Allergy & Immunology - U.S. FDA approves Clarinex-D 12 Hour
Angina - U.S. FDA approves Ranexa
Antibiotics - In vitro, in vivo studies support development of pharmacodynamic parameters to determine drug dose
Antimicrobials - Second study to test persistency of chlorhexidine hand sanitizer commissioned in Europe
Asthma - Exercise induced asthma impacts 1 in 6 Olympic athletes
Attention Deficit Hyperactivity Disorder - Drugmaker provides update on regulatory status of Sparlon
Attention Deficit Hyperactivity Disorder - U.S. FDA accepts new drug application for NRP104 as treatment for ADHD
Avian Influenza - Applications of Hemopurifier expanded to include avian influenza
Avian Influenza - Safety issues may hamper production of bird flu vaccine
Awards - Kaiser Foundation, CNN International announce new award for HIV/AIDS journalism in Africa
Bacteriology - Studies report 2 million Americans carry drug-resistant Staph bacterium
Bioterrorism - Pharmaceutical firm responds to call for acute radiation syndrome therapy for U.S. forces
Bipolar Disorder - Course of bipolar disorder in children described for the first time
Bronchopulmonary Dysplasia - U.S. FDA grants Surfaxin fast track designation for prevention and treatment of BPD
Business & Finance - Allergan extends expiration date of exchange offer
Business & Finance - Cancer drug developer posts net loss of $0.17 per share
Business & Finance - Cancer drug developer reports loss of $0.23 per share
Business & Finance - Company reports Q4 revenue of $132.7M, discusses remarketing of Tysabri
Business & Finance - Drug delivery-focused company receives notice of AMEX delisting
Business & Finance - Drug development company subsidiary CDE certified for new market tax credit program
Business & Finance - Healthcare company announces transfer of manufacturing part of Erie operations to Mexico
Business & Finance - Hematology-focused biotech firm adopts shareholder rights plan
Business & Finance - Pharmaceutical company regains Nasdaq compliance
Business & Finance - Pharmaceutical company reports Q4 05 revenues of $437,000, down from $2.6 million in Q4 04
Business & Finance - Pharmaceutical company shareholders approve spinout of targeted immunotherapy assets
Business & Finance - Polymun development and manufacturing agreement sold for $1 million
Business & Finance - Protein, antibody developer reports net loss of $73.2M for 2005
Business & Finance - Specialty oncology company completes merger, raises $5.9 million in private financing
Business Update - Surgical products, services companies partner to target correctional health market
Business Update - Zoll Medical signs 3-year contract with Novation for noninvasive cardiac support pump
Cancer Research - Genetics research may hold key to destroying cancer cells
Cancer Screening - Pennsylvania governor proposes giving more women access to breast and cervical cancer screening
Cancer Therapy - Analysis of Genasense trial confirms major efficacy variables in patients with melanoma
Cancer Therapy - Cancer organization updates to several clinical practice guidelines
Cancer Therapy - Enrollment complete in pivotal phase III trial of FavId for follicular B-cell NHL
Cancer Therapy - Multicenter phase II study with MKC-1 begins
Cancer Therapy - Phase I trial of dendritic cell vaccine in patients with colorectal cancer meets endpoint
Cancer Therapy - Reports advance knowledge in cancer therapy research
Cancer Vaccines - Geron clarifies license rights for cancer vaccines
Cancer Vaccines - Researchers describe findings in cancer vaccines studies
Cardiology - Sirolimus-eluting stent may reduce re-blockage in complex coronary lesions, study shows
Cardiovascular Disease - Nearly half of people who need cholesterol treatment don't get it
Cardiovascular Disease - Pharma company introduces heart disease campaign to help women with physician conversations
Cardiovascular Therapy - Phase III study examines ability of drug to slow atherosclerosis
Central Nervous System - Glutamate receptor agonist may be an effective tool for investigating stress-related CNS disorders
Clinical Trials - Enrollment opened in phase 2 trial of DNA vaccine against cytomegalovirus
Clinical Trials - Medical centers vary in disclosing conflicts of interest to clinical trial subjects
Clinical Trials - Phase 2 program of antisense drug in patients with familial high cholesterol initiated
Clinical Trials - Plans for phase 2 trial of anticancer agent in elderly poor-risk AML patients announced
Collaborations - Abbott Laboratories grants rights for new cancer and transplantation drug tests
Collaborations - Advanced gene expression service provider expands globally
Collaborations - Alliance signed for promotion and support of clinical trials
Collaborations - Biosciences company, Bristol-Myers Squibb extend the term of research agreement
Collaborations - Collaboration formed to provide primate-human gene expression and SNP assays
Collaborations - Collaboration to develop ophthalmic therapeutics built from synergistic drug combinations
Collaborations - Commercialization deal signed for atherosclerosis treatment
Collaborations - Deal signed in Taiwan for development of Immunogene therapy for cancer indication
Collaborations - Licensing and commercialization agreements expanded into Europe for IGN311
Collaborations - Locus announces research agreement with Eli Lilly and Company for protein kinase target
Collaborations - Louisiana court partners with Southern University to evaluate substance abuse protocols
Collaborations - Partners form joint Center for Systems and Computational Biology
Collaborations - Partnership forged to develop new solutions for assessing drug toxicity
Collaborations - Partnership formed to develop RNAi therapeutics for childhood cancer
Collaborations - Research and development collaboration with Astellas Pharma extended
Contracts - Dialysis products manufacturer signs Canadian distribution agreement with Genpharm, Inc.
Cystic Fibrosis - Denufosol proceeding to phase III trials in cystic fibrosis
DNA Research - Single-step, single-nucleotide polymorphism typing based on DNA hole transport achieved
Depression - Findings advance knowledge in depression research
Depression - Women with major depression at risk of relapse during pregnancy without medication
Dermatology - Survey shows majority of Americans did not know that OTC products can make scars worse
Diabetes Drugs - Approval and availability of Avandaryl (rosiglitazone maleate and glimepiride) announced
Diabetes Pathogenesis - Leptin inhibits stimulation of fatty acid uptake by insulin in differentiated adipocytes
Diabetes Therapy - Shakuyakukanzoto effect in diabetics may rely on descending noradrenergic neuron activation
Diabetes Therapy - KCP256 shows lower drug-induced hypoglycemia risk compared with sulfonylurea drugs
Diagnostics - A new radioreceptor assay detects signs of angiogenic inhibition in preclinical models
Diagnostics - Label change granted for Thyrogen
Diet & Nutrition - Retailer launches Women's Ultra Mega Bone Density supplement
Disease Associations - High blood pressure, kidney disease increase heart disease risk in older Americans
Drug Delivery - European Commission approves IONSYS
Drug Development - APEX-AMI pexelizumab trial to complete enrollment in March
Drug Development - Access to investigational chickenpox product expanded to meet U.S. supply
Drug Development - Arixtra administered the morning after orthopedic surgery prevented VTE
Drug Development - Biologics license application for cervical cancer vaccine is on track
Drug Development - CD46-transgenic mice were used to study replication-incompetent adenoviral vectors
Drug Development - Data on Phenserine and Posiphen for Alzheimer disease to be presented in Geneva
Drug Development - Dosing cycle completed on first patient in phase I trial of blood cancer drug
Drug Development - Dr. Gerald Yakatan joins allergy company's board of directors
Drug Development - Drugmaker provides CIP-Tramadol Extended Release update
Drug Development - European Design Examination Certificate granted for wound care management product
Drug Development - Good bioavailability reported from phase I trial of iclaprim
Drug Development - Hepatitis C candidate moves into preclinical development
Drug Development - Human T cell leukemia virus type 1 protease is target for anticancer drug design
Drug Development - IND application filed for anticancer drug with nanotechnology delivery platform
Drug Development - Icon retained for phase II/III trial for MBP8298 to treat multiple sclerosis
Drug Development - LgsKO mice show higher glucose tolerance and lower adiposity without fasting hypoglycemia
Drug Development - Lundbeck, collaborator to discover allosteric modulators of G-protein coupled receptors
Drug Development - Maryland Industrial Partnerships program approves 14 university-based research projects
Drug Development - NDA submitted to U.S. FDA for involuntary emotional expression disorder therapy
Drug Development - New subsidiary to accelerate RNAi therapeutics programs
Drug Development - Pharma company in phase II trials of therapeutic for wet AMD
Drug Development - Pharma company initiates clinical trials of antisense drug in cancer patients
Drug Development - Pharma company receives milestone payment from Merck for ubiquitin ligases research
Drug Development - Pharmaceutical firm focused on diseases of aging and diabetes provides clinical pipeline update
Drug Development - Phase I trial initiated with c-Met inhibitor in patients with multiple metastatic tumors
Drug Development - Phase I trial of Type 2 diabetes drug initiated
Drug Development - Phase I trial underway of skin patch for prevention of chemo induced emesis
Drug Development - Phase II trial of Hematide initiated in patients with anemia associated with cancer
Drug Development - Phase II trial of MF101 launched for treatment of menopausal symptoms
Drug Development - Positive results reported in phase III study of Entereg in postoperative ileus
Drug Development - Predictive modeling software company introduces new product for pharma companies
Drug Development - Prescription product with nutritional components for osteoarthritis introduced nationally
Drug Development - U.S. FDA grants final approval for testosterone gel 1% product
Drug Development - U.S. FDA grants orphan medicinal product designation for rare disease protein therapeutic
Drug Development - U.S. FDA requests additional data for Delta opioid agonist; application on hold
Drug Safety - Chain-owned pharmacies less likely to provide prescription label translations
Drug Safety - Report on drug withdrawal in U.S. notes effect on selective COX-2 inhibitor market
Escherichia Coli Vaccines - Escherichia coli vaccine strain is safe and immunogenic in healthy adults
Facilities - Aptamer-based therapeutic developer moves to new headquarters
Facilities - Healthcare management systems company to open fifth medical facility in California
Facilities - Pharma company divests AWD.pharma manufacturing plant in Dresden, Germany
Facilities - Sigma-Aldrich Group member forms entity to provide raw manufacturing materials
Finance - Analytical instruments company reports Q4 2005 revenue growth of 21%
Finance - Biopharmaceutical company focused on metabolic diseases files shelf registration statement
Finance - Biopharmaceutical company reports 2005 U.S. and Canada net sales of anti-HIV drug up 32%
Finance - Canadian biopharmaceutical firm reports 9% increase in revenue
Finance - Cancer drug developer reports loss of $0.99 per share, provides clinical pipeline update
Finance - Cancer immunotherapies developer receives delist determination from NASDAQ panel
Finance - Cancer vaccine developer completes $3M institutional financing
Finance - Cancer-focused biotech firm announces put option
Finance - Cancer-focused biotechnology company sets IPO of common stock at $6 per share
Finance - Chemically derived drug distributor posts decline in revenue
Finance - Company focused on age-related macular degeneration receives investment
Finance - Connecticut to receive mental health state incentive grant of $13.6 million over 5 years
Finance - DNA-focused biopharmaceutical company files $70 million shelf registration
Finance - Drug developer focused on respiratory diseases reports 75% increase in sales
Finance - Drugstore chain reports 0.9% same store sales increase for January 2006
Finance - Gastroesophageal reflux disease drug developer completes Series E financing
Finance - Gastrointestinal drug maker reports 10% increase in sales
Finance - Healthcare products company reports Q4 05 net revenue up 2% to $4.7 billion
Finance - Healthcare, drug company reports GAAP net Q4 05 sales of $2.3 billion, up 6% from year ago
Finance - Healthcare, life sciences company reports Q3 2006 revenue increase of 5% to $287.5 million
Finance - Hearing aid company reports full year 2005 net sales up 7%, down 3% in Q4
Finance - Israel-based generic drug company sets pricing of $1.25 billion of convertible debentures
Finance - Kindred Healthcare announces $100 million increase to available credit capacity
Finance - Lilly reports $3.879 billion in sales
Finance - MedImmune reports revenues of $1.2 billion
Finance - Myeloma foundation awards over $8 million in 2005 to Multiple Myeloma Research Consortium
Finance - Mylan Laboratories reports earnings per share of $0.25 for third quarter
Finance - Natural and organic products company reports record Q2 2005 sales up 10% from year ago
Finance - Neurobiological Technologies receives $1.4 million quarterly royalty payment related to Memantine
Finance - Neuroscience drug maker receives $4.2M from exercise of warrants
Finance - Neuroscience drug maker reports loss of $0.10 per share
Finance - Nutritional products company reports net sales of $455 million for first quarter
Finance - Oncology diagnostics-focused company reports 2005 revenues increased 26% to $68.5 million
Finance - Ophthalmology company reports 10.7% increase in sales
Finance - OrthoLogic reports net loss of 7.5 million or $0.20 per share for the fourth quarter
Finance - Pharma company announces Tarceva net sales of $25 million for fourth quarter
Finance - Pharma company announces intention to raise $40 million in new capital
Finance - Pharma company begins trading under symbol NHPI, announces $4.35 million private placement
Finance - Pharma company sales increase 16% in 2005
Finance - Pharma firm focused on Asian markets receives American Stock Exchange notification
Finance - Pharma giant reports 1.1% decline in sales
Finance - Pharmaceutical company reports revenues up 13% for fiscal Q3 2006 over year ago
Finance - Pharmaceutical company sets pricing of initial public offering at $9 per share
Finance - Pharmaceutical division to be separated from parent company
Finance - Pharmaceutical firm files amended report to the U.S. S.E.C.
Finance - Protein therapeutics developer prices initial public offering
Finance - Public offering of common stock priced by RNAi therapeutics company
Finance - Q4 2005 sales of Copaxone up 24% to $323 million, annual sales up 26%, company reports
Finance - Risperdal Consta maker reports second consecutive profitable quarter
Finance - SBIR grant to be used for study of drug for stroke patients
Finance - Sierra Health reports Q4 2005 net income of $28.3 million, up from $28 million a year ago
Finance - Specialty pharma company signs definitive agreement for $65 million private financing
Finance - TEDCO awards grant for a smallpox DNA vaccine delivery project
Finance - United American Healthcare reports total revenues for Q2 2006 down from year ago
Finance - Walgreen Co. reports January 2006 sales increase 11.8% over same month 2005
Food Safety - EPA registration for germicidal product received by food safety products company
Food Safety - Human clinical trials commenced on citroxin 02 ingestible
Gastroenterology - Gut protein protects against infection, intestinal breakdown
Gastroenterology - U.S. FDA grants approval for oral treatment for chronic idiopathic constipation in adults
Gastroesophageal Reflux Disease - Medicare increases reimbursement rate for Plicator procedure
Generic Drugs - Drug maker announces Aventis' preliminary injunction motion denied in Allegra litigation
Generic Drugs - Pharma company announces final U.S. FDA approval for alprazolam extended-release tablets
Generic Drugs - U.S. FDA approves ANDA for generic desmopressin acetate tablets
Genetics & Genomics - Genetic variation detection tool used on mutations associated with therapy in lung cancer
Genetics & Genomics - RNAi Consortium member introduces lentiviral shRNA gene family set for gene silencing
HIV/AIDS Drug Delivery - HIV Tat fusion proteins reduce brain injury following ischemic stroke
HIV/AIDS Drug Development - LC method provides accurate and precise analysis of ritonavir in soft capsules
HIV/AIDS Pharmaceutical Research - Extended-release clarithromycin well tolerated and bioequivalent to IR formulation
HIV/AIDS Prevention - Call issued for Anglo-French alliance to combat AIDS epidemic
HIV/AIDS Prevention - Journal takes in-depth look at HIV/AIDS over the past 25 years
HIV/AIDS Therapy - Sequencing antiretroviral drugs extends the suppression of HIV replication
Health Promotion - New consumer education campaign focuses on immune system threats
Healthcare Access - Pennsylvania nonprofit organization launches for-profit seniors franchise system
Healthcare Costs - Administration says Medicare drug coverage will drop overall costs substantially
Healthcare Costs - Generic drug makers speak out against President Bush's budget
Healthcare Coverage - State of South Carolina selects ActiveHealth Management to provide decision support services
Healthcare Coverage - Studies reveal mandates requiring businesses to provide health coverage are ineffective
Healthcare Coverage - U. of Michigan health plan partners to offer online health management tools
Hepatitis B Virus - U.S. FDA approves hepatitis B-specific immune globulin for acute exposure
Hepatitis C Therapy - U.S. FDA grants Civacir fast track designation for hepatitis C
Hepatitis C Therapy - U.S. FDA grants fast track designation to investigational oral HCV protease inhibitor
Hepatitis C Virus - CD81 activates naive B lymphocytes
Hepatitis Vaccines - HBV CpG-optimized protein and DNA vaccines perform poorly in chimpanzees
Influenza - Copper could help prevent the spread of flu infections
Influenza - Thiovir proven active against various influenza A viruses
Information Technology - Company launches online course for lab staff on creating documents to meet ISO standards
Information Technology - FFF Enterprises uses ERP product-tracking software in electronic drug pedigree system
Information Technology - Partners In Care participates in federally funded test of electronic prescribing program
Information Technology - Sanofi-aventis Group signs 3-year software, services contract for sales management system
Information Technology - Software simplifies connectivity between logic analyzers and oscilloscopes
Japanese Encephalitis - European Commission grants Japanese encephalitis vaccine orphan drug status
Kidney Cancer - Agency approves new treatment for gastrointestinal and kidney cancer
Legal Issues - Molecular diagnostics company, Innogenetics reach agreement and resolve patent litigation
Leukemia - License agreement signed to develop Fodosine for use in oncology
Licensing Agreements - License agreement set with Baylor, M.D. Anderson to develop antimicrobial coated implants
Licensing Agreements - Potential migraine compound licensed to BTG
Macular Degeneration - Macugen receives European regulatory marketing approval as AMD treatment
Macular Degeneration - Phase I study of VEGF Trap shows rapid, substantial and prolonged reductions in retinal thickness
Market Analysis - China to become a world leader in stem cell research, according report
Market Analysis - U.S. has the largest over-the-counter drug market in the world, according to new report
Marketing - Ascend Therapeutics selects sales and marketing services provider to promote EstroGel
Marketing - Promotion "arms race" looks set to continue for the foreseeable future
Marketing - U.S. distribution rights for Medtronic anastomotic vascular surgery device acquired
Medical Devices - Immunoprofiling platform with global population coverage launched
Medicare - Pennsylvania governor seeks to expand comprehensive drug package for seniors
Medicare - U.S. HHS secretary issues progress report on Medicare Prescription Drug Benefit
Melanoma Vaccines - Research add new data to melanoma vaccines body of knowledge
Melanoma Vaccines - Researchers' work adds to melanoma vaccines body of knowledge
Menopause - New look at HRT highlights the value of starting soon after menopause
Mental Health - Lyrica receives positive opinion from CHMP for treatment of generalized anxiety disorder in adults
Mental Health - Men need lifestyle with work and play to prepare for retirement, Harvard publication says
Mental Health - Research firm finds launch of triple reuptake inhibitors will drive the market for depression
Mergers & Acquisitions - Agreement signed to acquire European drug discovery service company
Mergers & Acquisitions - Angiogenesis-focused biopharmaceutical firm merges with eClic, Inc.
Mergers & Acquisitions - Company focused on glaucoma acquires Pro Top and Mediking
Mergers & Acquisitions - Drug discovery company signs definitive agreement to acquire Montigen Pharmaceuticals
Mergers & Acquisitions - Final results of merger consideration regarding acquisition of Ivax announced
Mergers & Acquisitions - Innovate will acquire 50% interest in pancreatic chemoresistance inhibitor
Mergers & Acquisitions - Oncology services company to acquire ivpcare
Mergers & Acquisitions - Private equity firm acquires majority interest in Bioniche Pharma Group Limited
Mergers & Acquisitions - Purchase of continuing medical education company completed
Mergers & Acquisitions - Rapid testing devices developer announces acquisition of Accu-Stat Diagnostics, Inc.
Mergers & Acquisitions - Research firm acquires Millennium Research Group
Migraine Headaches - U.S. FDA approves new formulation of Imitrex injection
Muscular Dystrophy - Biopharma company initiates phase II study of PTC124 in Duchenne muscular dystrophy
Neuroscience - Research paper validates radioiodinated clioquinol as a biomarker for beta-amyloid
Obesity Epidemiology - Constant beta3-adrenoceptor stimulation by KTO-7924 improves lipid metabolism in obese rats
Oncology - Study emphasizes women should see gynecological oncologists for ovarian cancer treatment
Ophthalmology - U.S. FDA approves expanded use of Xibrom to treat post-cataract surgery pain
Ophthalmology - University eye institute, neurology program join to offer ophthalmology diagnostic program
Osteoporosis - CHMP recommends first quarterly IV for postmenopausal osteoporosis for approval
Osteoporosis - Pharma companies collaborate to develop and commercialize nasal spray for osteoporosis
Osteoporosis - Premenopausal women with diabetes have more fractures, less bone density, study shows
Osteoporosis - Researchers describe findings in osteoporosis studies
Pain Management - U.S. FDA accepts IND for OxyQD
Pain Management - U.S. FDA grants orphan drug status to high-concentration pain management therapy for PHN
Pancreatic Insufficiency - First of two phase III studies initiated for EUR-1008M in patients with EPI
Patents - Company receives second U.S. patent protecting polymer composition of delivery vehicle
Patents - Patent allowed for heat shock protein-derived peptides
Patents - Patent covers unique method of isolating adult stem cells
Patents - Pharma announces Federal Circuit Court of Appeals remands OxyContin patent case
Patents - Provectus receives fourth pharmaceutical patent for anticancer agents
Patents - Transdermal science company serves patent infringement notice for insulin delivery system
Pediatric Obesity - Women's volunteer group launches 2006 childhood obesity initiative "Kids in the Kitchen"
Pediatrics - New moms identify infant gas as stressor for babies and moms
Peripheral Arterial Disease - U.S. FDA fast track status granted for rifalazil in peripheral arterial disease
Personnel - Argeris 'Jerry' Karabelas named non-executive chair of drug delivery company board
Personnel - Biopharma company elects Jean-Pierre Millon as chairman of the board
Personnel - Biopharmaceutical company names Thomas E. Rathjen vice president of investor relations
Personnel - Biotech company names Neil Roth acting president
Personnel - Biotechnology Council of New Jersey's board of trustees elects Dr. Leslie J. Browne
Personnel - Chemistry service firm adds two key human resources professionals
Personnel - Clinical research organization adds three experts to global product development services group
Personnel - Contract research organization names Sara Vidmar executive director for medical devices
Personnel - David B. Nash, MD, and Bruce Morra, PhD, named to InforMedix, Inc. board
Personnel - Drug delivery pharmaceutical company announces workforce reduction
Personnel - Drug delivery systems company appoints Mento A. Soponis chairman and CEO
Personnel - Drug development software company adds staff in product training and strategic consulting services
Personnel - Duncan Higgons joins biopharma as executive vice president, business operations
Personnel - Former U.S. Surgeon General Joycelyn Elders joins pharmaceutical company
Personnel - George Pontiakos named president, CEO, North American operations, of nutrition company
Personnel - Infectious disease-focused pharmaceutical firm appoints chairman of the board
Personnel - Kenneth G. Faulkner named VP, business development, of clinical trials services company
Personnel - Molecular diagnostics company announces management team changes
Personnel - Nanomaterials developer hires Dr. Jayant Tatake as VP research and development
Personnel - Nasal drug delivery developer forms scientific advisory board
Personnel - New thoracic cancer advisory board formed
Personnel - Ophthalmology firm promotes F. Michael Ball to president
Personnel - Paul J. Gallagher named senior vice president, enterprise operations, of WellPoint, Inc.
Personnel - Peter Fellner named non-executive director at vaccines company
Personnel - Pharma company names Mark A. Varney as COO and chief scientific officer
Personnel - Pharma consulting company names Glenn A. Stiegman, III as vice president
Personnel - Pharma product development company appoints Rick A. Bright as VP vaccine research
Personnel - RNAi therapeutics-focused company appoints Akshay Vaishnaw as VP
Personnel - Radioisotopes company appoints Christopher Wagner as senior VP of sales and marketing
Personnel - Respiratory disease-focused drug maker appoints William J. Newell as president
Personnel - Rich Daly returns to pharma company as vice president of marketing and commercial strategy
Personnel - Robert F. Apple named senior VP and chief financial officer at drug delivery firm
Personnel - Sirtris names Garen Bohlin chief operating officer
Personnel - Walgreens names William M. Handal senior vice president of eastern store operations
Pertussis Vaccines - New data illuminates research in pertussis vaccines
Pharmaceutical Research - Drug delivery company, Donaldson launch jointly developed nanofiber cell culture product
Pharmaceutical Research - Market research firm introduces electronic format of Pharmcor report
Pharmaceutical Research - Phosphosulfomannan angiogenesis inhibitor analogues act variably
Philanthropy - Foundation receives grants from The Baxter International Foundation to help with disaster recovery
Pompe Disease - Biotech company receives positive opinion for Myozyme from European regulatory committee
Premenstrual Dysphoric Disorder - U.S. FDA clarifies status of YAZ PMDD application
Product Licensing - Beverly Hills California physician licenses Prometa physiological protocols
Product Licensing - Hepatitis C virus license agreement signed with Chiron
Product Licensing - Molecular tests company licenses newly discovered coronavirus CoV-NL63 to bioMerieux
Product Licensing - Pharma company licenses mitochondrial disease technology from Georgetown University
Product Licensing - Reproductive health organization licenses Biosyn-patented microbicides for the prevention of HIV
Product Licensing - Worldwide rights obtained for cetrorelix in benign prostate hyperplasia
Professional Education - Emergency nurses group selects online learning service to develop geriatric care course
Prostate Cancer - Data show bicalutamide 150mg plus radiotherapy extends survival in locally advanced prostate cancer
Protein Production - Multi-product immunoassays are suitable to monitor host cell protein impurities
Public Health - Campaign launched raise awareness of childhood cancer in emerging countries
Pulmonary Hypertension - Drugmaker in-licenses pulmonary hypertension compound for development
Respiratory Medicine - Group rankings shows no city is safe from asthma
Respiratory Medicine - Hydrocortisone therapy improves mechanical ventilator weaning
Rotavirus - Newly-licensed rotavirus vaccine traveled long road in development
Sexual & Reproductive Health - Soaring U.K. rates of Chlamydia infection partly due to more sensitive tests
Sleep Disorders - Regulatory update provided on status of NUVIGIL
Sociology Research - Bounded awareness, cognitive blinders can prevent risk recognition in decision making
Spinal Muscular Atrophy - Licensing agreement aims to boost spinal muscular atrophy drug discovery efforts
Staffing - Kenexa selects vendor for employment process outsourcing services
Staffing - Recruitment services firm establishes specialized healthcare group
Thyroid Cancer - U.S. FDA grants fast track designation for Zactima for the treatment of thyroid cancer
Tobacco Use - Healthcare supplier receives U.S. FDA approval to market nicotine lozenges
Tobacco Use - Low level laser therapy for smoking cessation clinic opens in New York City
Tonsillitis - Parents happier with alternative to liquid medications for tonsillectomy
Transplant Medicine - Findings describe new data in transplant medicine research
Transplant Medicine - Findings in transplant medicine provide new insights
Tuberculosis Vaccines - Advances in tuberculosis vaccine development summarized
Type 2 Diabetes - PC-DAC:Exendin-4 to advance into human clinical testing for type 2 diabetes
Ulcerative Colitis - European Medicines Agency CHMP recommends approval of Remicade for ulcerative colitis
Vaccine Development - Protection induced by BCG vaccine can be augmented using plasmid DNA
Return to Top of Page